Which Dog Joint Chews Can You Actually Trust? The Seal, the Lot Test and the Trial Each Vouch for a Different Thing

Do not buy a joint chew because the word trusted appears anywhere near it. There is no regulator behind that word: the FDA decided in 1996 that the human supplement law does not cover animals, so nothing checks a dog joint chew before it reaches the shelf. Trust is therefore not a feeling you can have about a brand. It is a stack of documents, and each one vouches for a different thing. The NASC seal vouches for the factory. A lot test vouches for the chew. A clinical trial vouches for the dog. We read the member list, the chemistry and the trials, and below is which chews hold which receipt, and which hold none.

Why there is no regulator behind the word#

The reason the joint aisle feels like a trust exercise is that legally it is one. In April 1996 the FDA published a notice in the Federal Register concluding that animal dietary supplements are not covered by the Dietary Supplement Health and Education Act, the 1994 law that created the human supplement category. The agency's reasoning was that very few substances that qualify as supplements for people have any established history of safe use in any animal, and that each species requires different nutrients, absorbs and metabolizes them differently, and can exhibit different toxic reactions.^[1]

So a joint chew for a dog is, in law, one of two things. If it claims only to feed the dog, it is an animal food. If it claims to treat, prevent or mitigate arthritis, it is a new animal drug, and a new animal drug can only be marketed after FDA approval.^[1] Almost every chew on the shelf sits in the gap between those two definitions, marketed with the language of the second and the paperwork of the first. The agency has described products in that gap as technically in violation but a low enforcement priority unless a health concern arises.^[2] When it does act, it acts under the drug provisions: a warning letter of 12 November 2024 to a dog-supplement maker cited claims to reduce the frequency of seizures as making the product an unapproved new animal drug under section 512 of the Act.^[3]

That is the whole regulatory picture. Nobody tests the chew before sale. Nobody is required to check the label against the contents. The industry noticed this thirty years ago and built its own answer, which is the next section, and the answer is narrower than the seal on the bag suggests.

What the NASC seal certifies, and what it does not#

The National Animal Supplement Council was formed in 2001, in its own words, in response to the lack of an appropriate legal category for dietary supplements for animals.^[4] It is a trade association. Its Quality Seal is a programme its members pay into and are audited against, and it is a genuinely useful document as long as you read what it says rather than what it looks like.

What a company has to do to display the seal, from the NASC's own page and its 2025 fact sheet: pass an independent third-party audit of its facility every two years, keep a written quality-control manual with standard operating procedures, run an adverse event and complaint system that reports into the NASC's own database, comply with the NASC's labeling guidelines including the FDA-recommended caution statements, and submit to random product testing by an independent laboratory to check that products meet label claim.^[5][6] The adverse event system, NAERS, monitors over 1,400 ingredients and more than 6,000 products, according to the council's own home page.^[7]

Read that list again for what is not on it. The seal is awarded to a company, not a product. The audit is of a facility and a paper system. The random testing is real, but it is random, unpublished by product, and the council does not name the companies that fail. Nothing in the programme tests whether a chew does anything for a dog, and the NASC does not claim it does. The seal is a promise about the factory. It is not a promise about the dog.

dogorthopedic.com

The seal's one hard limit, and the reason this article exists, is what happens when you check who holds it. On 11 September 2026 we read the NASC member list, where a green check mark marks the companies audited for supplements. FoodScience, which makes VetriScience and Pet Naturals, is there with the check. So are Pet Honesty, Zesty Paws, Vetnique Labs, which distributes YuMOVE in the United States, NaturVet, and Pet HealthWorks, which distributes Antinol Plus.^[8] Nutramax Laboratories, the maker of Cosequin and Dasuquin, is not on the list at all. We first found that on 19 August and confirmed it again today. At least one review site says otherwise. A Dasuquin review at dogsupplementhub.com, updated January 2026, states that the product "carries the NASC Quality Seal" and that the seal "confirms that the label accurately reflects the contents." The council's own list says the company is not a member, and the council's own page says the seal is an audit of process.

That is not a finding against Nutramax. It is a finding about the seal. What Nutramax publishes instead is a different document: an annual Good Manufacturing Practice certification from Underwriters Laboratories, audited against 21 CFR Part 111, the federal rule for human dietary supplement manufacture, which the company announced as its third consecutive year in 2022,^[9] and a statement on its quality page that every supplement is tested for contaminants, backed by more than 80 quality checks, and guaranteed to meet label claims.^[10] A self-declared guarantee is weaker than an outside audit, and the human rule is a federal regulation where the NASC standard is a trade association's. The point is that the brand with no seal has a different receipt, not no receipt, and a buyer sorting the aisle by the seal alone would have thrown out the most-documented product in it.

What happens when somebody measures the chews#

The seal audits process. The only way to know what is in a chew is to measure a chew, and the measurements that exist are the reason to take none of this on faith.

The first systematic look was in 2000, when Adebowale and colleagues analysed marketed glucosamine and chondroitin products by liquid chromatography: fourteen glucosamine products, eleven chondroitin products, and a further 32 chondroitin products by titration. Deviations from label claim ranged from 0 percent to over 115 percent, and the products retailing at a dollar or less per 1,200 mg of chondroitin were, in the authors' words, seriously deficient, at less than 10 percent of label claim.^[11] Those were products from the general marketplace rather than the pet aisle, but the raw materials are the same ones the pet aisle buys, and the price finding is the one to carry with you.

The animal-side chemistry came from Ontario Veterinary College in 2006. Oke and colleagues tested 23 glucosamine-containing joint supplements marketed for horses. Thirteen of the 23 contained less glucosamine than the label claimed, three contained under 30 percent of it, and one contained none. Dosing recommendations across the products ranged from 1,800 to 10,000 mg a day.^[12][13]

Then the dog products themselves. In July 2009 ConsumerLab reported that four of the six pet joint supplements it tested failed its standards, one containing only 17 percent of its promised chondroitin, and in the same report the NASC said its own random testing of 87 brands had found 28 percent falling short of label claim. The council did not name them.^[14] In a later round, reported in early 2013, ConsumerLab tested 13 dog and cat mobility products and failed four. One, a chicken jerky treat sold as a joint supplement, measured at 6 percent of its claimed glucosamine and 15.9 percent of its claimed chondroitin. Cosequin DS, in the same round, met its stated amounts.^[15] ConsumerLab's full pet review sits behind a subscription and we could not read it directly today; the figures above are as reported at the time, and we say so.

Three things to take from the chemistry. The failures are not rounding errors; they are products at a tenth of their label or less. The failures cluster at the cheap end, which is exactly where a reader who has just been quoted a surgery is shopping. And every one of the tests above is a decade or more old; no newer test we could read turned up in our search. The absence of recent data is not evidence that the problem was fixed. It is evidence that whoever is looking does not publish the names.

“Because your dog can't tell you how much pain he or she is in.”

The delay this site is built around usually happens before the diagnosis. There is a second version of it that happens after: the six or eight weeks a dog spends on a chew while the household waits to see whether it is working, and the chew contains a tenth of what the label says. The dog gets no better. The owner concludes the category does not work, or the dog is past helping. Neither is what happened. What happened is that nobody measured the chew, and the dog could not tell her.

The four documents, and which chews hold which#

Here is the reconciliation, product by product, for the chews this site already covers plus the one soft gel that keeps coming up. Every cell is something we read at source on the date given, and where a cell says none found, we looked.

The table is the argument, so read it slowly. The only chew in the aisle with a blinded trial of the exact product is the one that lost, and it is also the one with the most complete panel and the most outside audit paper, and it has no seal. The seal-holders, as a group, are the products whose panels you cannot check, because a proprietary blend makes the dose arithmetic impossible, and the seal-holders above evidently carry blends on their panels without losing the seal. The product with a trial it won is not a chew at all, and its two trials came from one research group paid by the compound's owner.^[16][17]

None of that tells you which product works. It tells you which product you can check, and a product you cannot check is not one you can trust; it is one you have decided to believe.

dogorthopedic.com

Which chew, then#

Before a product, the free thing. Body weight is the modifiable factor with evidence from both ends of a dog's life. In the lifetime Labrador study, dogs fed 25 percent less than their paired littermates lived longer and had a lower prevalence and later onset of radiographic hip osteoarthritis, with median first detection at 12 years against 6.^[18][19] In dogs already obese and arthritic, lameness scores improved once weight loss passed about 6 percent of body weight over 16 weeks.^[20] A body condition score and a weighed ration cost nothing, and are the subject of our dosing-by-weight guide. No chew on this page has evidence as strong as a lean dog. Start there if you have not.

Then, if you are going to buy a chew, buy on documents.

Dasuquin with MSM is our answer to the question as typed, and the reason is the paper trail, not the seal it does not have. Every active is printed per chew, so you can do the dose arithmetic for your own dog. The maker guarantees label claim under an annual outside audit. Its sibling passed the only independent content test we can point at. And a tub sold under this name was the glucosamine arm of a blinded, placebo-controlled force-plate trial, where it did not beat placebo; the paper prints four actives where today's panel prints eight, so that receipt reaches the name, not the batch.^[16] We keep saying that last part because it is the most trustworthy document on this page: a company that lets its product be tested in a design that can fail it, and then leaves the result in the literature, has told you something no seal can. The downsides are real and we print them on the card: no seal, no calorie figure published on any surface, a fish-oil base that rules it out for a dog on a fish-free elimination diet, and a dose chart that stops at 120 lb. The tablet version drops the fish oil and, at the two Amazon prices we recorded on 4 September 2026, about $17 a year.

Antinol Plus is not a chew, and we card it because it is the only product in this aisle holding both the seal and a trial it won. Pet HealthWorks is on the NASC list with the green check; the two blinded trials, in 2023 and 2024, measured dogs on a force plate rather than asking owners.^[17] What it does not have is independence, since both trials were funded by the company that owns the compound and came from one research group, or a price a normal household carries indefinitely: about $608 to $1,216 a year for a 70 lb dog at the label's maintenance range of two to four soft gels a day and the direct store's $124.95 per 150 count, against roughly $207 for Dasuquin at maintenance.^[21] And its own website disagrees with itself about how many trials there are, four on the homepage and two on the product page, read the same day.^[21] We wrote the full comparison for the reader deciding between them.

YuMOVE and Zesty Paws carry the seal. They are in the comparison table above so you can see their prices and panels side by side, and we do not give either a rank, because the seal is the only one of the four documents either holds. If the seal is the thing you want, YuMOVE's chondroitin is undisclosed and its own maker cannot agree whether a 70 lb dog needs one chew a day or three, which by our arithmetic on the $69.99 180-count is the difference between about $142 and $426 a year;^[22] Zesty Paws puts its actives in a blend, prints two different MSM figures on two of its own surfaces, and the only lot-number test lookup on its site is titled for its CBD products.^[23] Both are covered in detail on their own pages. Neither is a bad product. Both are products you have to believe rather than check.

How to check any chew yourself in ten minutes#

This is the part to forward, because it works on a product we have never heard of.

1. Look the company up, not the product. Search the NASC member list at nasc.cc/members for the manufacturer's legal name. A green check under "audited for supplements" is the seal. No entry means no seal; it does not mean a bad product, it means you need one of the other documents.
2. Turn the bag over and count the numbers. Every active should have its own milligram figure per chew. If the actives sit under one "proprietary blend" total, the dose cannot be checked against any study, and that is the manufacturer's choice, not an accident.
3. Ask for the certificate of analysis for your lot. Email the company with the lot number from the bag and ask for the third-party CoA showing potency against label claim. A company that measures its product has this document on file. One that will not send it has left you nothing to check.
4. Do the price test from the chemistry. Adebowale found the products at a dollar or less per 1,200 mg of chondroitin were the ones under 10 percent of label. Work out what you are paying per gram of the active. If it is implausibly cheap, the 2000 data says it probably is.
5. Run your own trial. Score your dog before you start, using the free pain checklist, give the product at the label dose for six weeks, and score again. Change nothing else. This is the only document about your dog that will ever exist, and it is the one that decides whether the reorder happens.

What to do this week#

If a chew is already in the cupboard, spend ten minutes on the checklist above before the next reorder. If the company is not on the list and the panel is a blend and nobody answers the CoA email, you have learned something for the price of an email, and the dose-by-weight guide will tell you what a checkable product should contain for your dog's size.

If you are choosing for the first time, buy the product you can check, weigh the dog, write down a score, and set a date six weeks out. The delay this site exists to shorten is usually the months before the diagnosis. The weeks a dog spends on an unmeasured chew are the same delay wearing a label, and the label is the only thing that cannot tell you.

Sources#

1. Food and Drug Administration. "Inapplicability of the Dietary Supplement Health and Education Act to Animal Products." Federal Register. 1996;61(78):17706-17708, 22 April 1996. govinfo.gov — read 11 September 2026: "FDA has concluded that animal dietary supplements are not covered by the DSHEA"; products claiming to treat disease are animal drugs requiring approval.
2. Thompson Coburn LLP. "Animal supplements still in limbo, facing increased FDA scrutiny." 13 August 2015. thompsoncoburn.com — the agency's position that such products are technically in violation but a low enforcement priority absent a health concern.
3. Food and Drug Administration. Warning letter to Nutrition Strength Ltd., reference 696350, 12 November 2024. fda.gov — seizure and anaemia products, not joint products, cited as unapproved new animal drugs under section 512.
4. National Animal Supplement Council. "Historical summary." nasc.cc — read 11 September 2026: formed in 2001; 1996 Federal Register notice; membership of roughly 300 finished-product companies.
5. National Animal Supplement Council. "NASC Quality Seal." nasc.cc — read 11 September 2026: independent audit, quality-control manual, adverse event system, labeling guidelines, random product testing by an independent lab.
6. Pets+ Magazine. "NASC fact sheet." May 2025. petsplusmag.com — "NASC members must pass a comprehensive third-party audit every two years."
7. National Animal Supplement Council. Home page. nasc.cc — read 11 September 2026, in the rotating text block: "Created and implemented the NASC Adverse Event Reporting System (NAERS®), which today monitors over 1,400 ingredients and more than 6,000 products."
8. National Animal Supplement Council. "Member list." nasc.cc — read 11 September 2026: green check under "audited for supplements" for FoodScience, LLC (VetriScience and Pet Naturals), Pet Honesty, Zesty Paws, Vetnique Labs, NaturVet and Pet HealthWorks, Inc.; no entry for Nutramax or Dogswell. Also read 19 August 2026 with the same result for Nutramax.
9. Nutramax Laboratories. "Nutritional supplement manufacturer Nutramax Laboratories exceeds industry standards for quality." Company media release, 26 May 2022. nutramaxlabs.com — annual UL GMP certification "based on 21 CFR Part 111," third year.
10. Nutramax Laboratories. "Our quality." nutramaxlabs.com — read 11 September 2026: "tested for harmful contaminants, backed by more than 80 quality checks, and guaranteed to meet label claims." No NASC reference anywhere on the site.
11. Adebowale AO, Cox DS, Liang Z, Eddington ND. "Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials." Journal of the American Nutraceutical Association. 2000;3(1):37-44. Abstract as indexed by OpenAlex, read 11 September 2026: deviations "from as low as 0% to over 115%"; products at one dollar or less per 1,200 mg chondroitin "seriously deficient (less than 10% of label claim)."
12. Oke S, Aghazadeh-Habashi A, Weese JS, Jamali F. "Evaluation of glucosamine levels in commercial equine oral supplements for joints." Equine Veterinary Journal. 2006;38(1):93-95. doi:10.2746/042516406775374306. PMID 16411594. The full text is paywalled; figures taken from source 13.
13. Mississippi State University Extension Service. "Equine joint supplementation: does it really work?" Publication P3646, February 2024. extension.msstate.edu — "13 of the 23 products contained less of the active ingredient than advertised on the label, with three containing less than 30 percent and one containing no glucosamine at all"; dosing recommendations "varying from 1,800 to 10,000 mg/day."
14. Associated Press, via NBC News. "Many pet supplements don't meet claims." 9 July 2009. nbcnews.com — ConsumerLab: four of six pet joint supplements failed, one with 17 percent of promised chondroitin; NASC: 87 brands tested, 28 percent short, names not published.
15. Truth about Pet Food. "Pet supplements caught lying." Early 2013 (earliest reader comment dated 10 January 2013), reporting ConsumerLab's joint supplements for pets review. truthaboutpetfood.com — 13 dog and cat mobility products tested, four failed; Dogswell Happy Hips at 6 percent of claimed glucosamine and 15.9 percent of claimed chondroitin; Cosequin DS met its stated amounts. ConsumerLab's own review page returned HTTP 403 to us on 11 September 2026 and is subscription-only.
16. Kampa N, Kaenkangploo D, Jitpean S, Srithunyarat T, Seesupa S, Hoisang S, Yongvanit K, Kamlangchai P, Tuchpramuk P, Lascelles BDX. "Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: a prospective, block-randomized, double-blinded, placebo-controlled clinical trial." Frontiers in Veterinary Science. 2023;10:1033188. doi:10.3389/fvets.2023.1033188 — the glucosamine arm was Dasuquin with MSM; it did not separate from placebo on the force plate. Discussed in full on our Antinol vs Dasuquin page.
17. Kampa N, Kaenkangploo D, Jitpean S, Srithunyarat T, Seesupa S, Hoisang S, Yongvanit K, Kamlangchai P, Tuchpramuk P, Lascelles BDX. "Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), Biota orientalis extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study." Frontiers in Veterinary Science. 2024;11:1464549. doi:10.3389/fvets.2024.1464549 — the second EAB-277 force-plate trial, same research group, funded by Pharmalink; detailed on our Antinol Plus page.
18. Kealy RD, Lawler DF, Ballam JM, et al. "Effects of diet restriction on life span and age-related changes in dogs." JAVMA. 2002;220(9):1315-1320. doi:10.2460/javma.2002.220.1315
19. Smith GK, Paster ER, Powers MY, et al. "Lifelong diet restriction and radiographic evidence of osteoarthritis of the hip joint in dogs." JAVMA. 2006;229(5):690-693. doi:10.2460/javma.229.5.690
20. Marshall WG, Hazewinkel HA, Mullen D, De Meyer G, Baert K, Carmichael S. "The effect of weight loss on lameness in obese dogs with osteoarthritis." Veterinary Research Communications. 2010;34(3):241-253. doi:10.1007/s11259-010-9348-7
21. Antinol Plus US store. Product and home pages, us.antinolplus.com — read 11 September 2026: 150 count $124.95; maintenance "2-4 soft gels daily" at 45 lb and over; "4 double-blind clinical studies" on the home page, "2 double-blind, controlled clinical trials" on the product page; no calorie figure published.
22. YuMOVE Hip and Joint for large dogs, 180 count. Amazon listing B0FDL8TXNZ — $69.99, in stock, Vetnique Labs buy box, read via the Amazon Creators API 11 September 2026. The maker's one-chew versus three-chews-a-day contradiction for a 70 lb dog is documented on our YuMOVE page.
23. Zesty Paws. "CBD product test results." zestypaws.com — read 11 September 2026: the only lot-number lookup on the site, titled for CBD products; no laboratory named.